AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUREN PHARMACEUTICALS LTD

12.800

-0.100-0.78%

Volume:331.90K

Turnover:4.28M

Market Cap:1.62B

PE:11.15

High:13.135

Open:12.910

Low:12.760

Close:12.900

52wk High:22.985

52wk Low:8.610

Shares:126.64M

Float Shares:108.39M

Volume Ratio:0.77

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.148

EPS(LYR):1.086

ROE:54.96%

ROA:41.13%

PB:5.01

PE(LYR):11.79

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NEUREN PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

2001

Employees:

8

Office Location:

117 Camberwell Road,Suite 1.01,Hawthorn East,Victoria,Australia

Website:

http://www.neurenpharma.com

Zip Code:

3123

Phone:

Fax:

- -

Introduction:

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as is in Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591 that is in preclinical development for the treatment of Phelan-McDermid, Angelman, and Pitt Hopkins syndromes. In addition, it provides development services; and holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Camberwell, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NEU.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":12.8,"timestamp":1771305120000,"preClose":12.9,"halted":0,"volume":331895,"delay":0,"changeRate":-0.007751937984496096,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":1.147709,"marketStatus":"Not Yet Opened","change":-0.1,"latestTime":"02-17 16:12:00 AEDT","open":12.91,"high":13.135,"low":12.76,"amount":4277982,"amplitude":0.02907,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.147709,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771369200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":12.9,"openAndCloseTimeList":[[1771282800000,1771304400000]],"volumeRatio":0.7721763835129736,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"41.13%","roe":"54.96%","lyrEps":1.086099,"volumeRatio":0.7721763835129736,"shares":126639526,"dividePrice":0,"high":13.135,"amplitude":0.02907,"preClose":12.9,"low":12.76,"week52Low":8.61,"pbRate":"5.01","psRate":"7.41","week52High":22.985,"institutionHeld":0,"latestPrice":12.8,"eps":1.147709,"divideRate":0,"volume":331895,"delay":0,"ttmEps":1.147709,"open":12.91,"prevYearClose":18.61,"prevWeekClose":12.75,"prevMonthClose":16.69,"prevQuarterClose":18.61,"fiveDayClose":13.51,"twentyDayClose":18.42,"sixtyDayClose":18.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":20376907,"yearFounded":2001,"employeeNum":8,"address":"117 Camberwell Road,Suite 1.01,Hawthorn East,Victoria,Australia","zipCode":"3123","officePhone":"61 3 9092 0480"},"stockCompanyDetail":{"websiteUrl":"http://www.neurenpharma.com","stockEarnings":[{"period":"1week","weight":-0.0526},{"period":"1month","weight":-0.3312},{"period":"3month","weight":-0.2998},{"period":"6month","weight":-0.2614},{"period":"1year","weight":-0.0376},{"period":"ytd","weight":-0.3122}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.015},{"period":"3month","weight":0.0447},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2039},{"period":"ytd","weight":0.0088}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as is in Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591 that is in preclinical development for the treatment of Phelan-McDermid, Angelman, and Pitt Hopkins syndromes. In addition, it provides development services; and holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Camberwell, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.062739},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.046478},{"month":3,"riseRate":0.47619,"avgChangeRate":0.356036},{"month":4,"riseRate":0.428571,"avgChangeRate":0.02071},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.04108},{"month":6,"riseRate":0.666667,"avgChangeRate":0.107096},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.047079},{"month":8,"riseRate":0.428571,"avgChangeRate":0.013034},{"month":9,"riseRate":0.619048,"avgChangeRate":0.114557},{"month":10,"riseRate":0.619048,"avgChangeRate":0.072663},{"month":11,"riseRate":0.47619,"avgChangeRate":0.032447},{"month":12,"riseRate":0.333333,"avgChangeRate":0.026009}],"exchange":"ASX","name":"NEUREN PHARMACEUTICALS LTD","nameEN":"NEUREN PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":null}}